February 9, 2022 Gamida Cell Initiates Rolling Submission of Biologics License Application for Omidubicel View Article
December 13, 2021 Gamida Cell Presents Two-Year Survival Data for GDA-201 and Resource Utilization Analysis for Omidubicel at 63rd ASH Annual Meeting View Article
February 11, 2021 Hope grows for blood cancer patients, as cell therapy firm’s key trial succeeds View Article
December 21, 2020 Gamida Cell Announces Closing of $75 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares View Article
October 13, 2020 Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration View Article
